首页 >
法规速递
-
Document: Fingolimod capsules 0.25 and 0.5 mg product-specific bioequivalence guidance-2025/7/29
2025-07-30查看详情 > -
关于公开征求《预防用mRNA疫苗药学研究技术指导原则（征求意见稿）》意见的通知-2025/9/16
2025-09-17查看详情 > -
国家药监局关于开展化妆品电子标签试点工作的通知-2025/10/20
2025-10-21查看详情 > -
Page: Organisation Management Service (OMS)-2025/11/21
2025-11-24查看详情 > -
Document: Quality Review of Documents (QRD) working group plenary meeting dates-2025/12/16
2025-12-17查看详情 > -
Document: Agenda - PCWP and HCPWP joint meeting February 2026-2026/1/30
2026-02-02查看详情 > -
New and Revised Draft Q&As on Biosimilar Development and the BPCI Act (Revision 4)-2026/3/9
2026-03-10查看详情 > -
Document: CHMP PROM minutes for the meeting on 6 October 2025-2026/4/8
2026-04-09查看详情 > -
Document: Questions to EMA on midazolam-2026/5/22
2026-05-25查看详情 > -
国家药监局药审中心关于发布《同名同方药研究技术指导原则（试行）》的通告(2022年第48号)-2022/12/27
2022-12-29查看详情 >
